isabelobrien, Author at European Medical Journal - Page 10 of 29

Christ Toth, CEO, Vantive on a blue and yellow background

5 minutes with... Chris Toth, CEO, Vantive

The former Baxter leader talks about the founding of Vantive, the challenges facing kidney patients, improving access to dialysis and more.

Cartoon of London houses of parliament

Britain explores Eli Lilly’s obesity drug to tackle long-term sickness

The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people back to work.

The word spotlight on a blue background

Spotlight: September 2024

Catch up on all the biggest news to hit the pharmaceutical industry this September, including new appointments, mergers and acquisitions, approvals and more.

Doctors in a surgery room standing in a line

Lord Darzi’s report on the NHS: What pharma needs to know

For the pharmaceutical industry, this situation highlights ways to step in as partners in healthcare innovation and support the NHS during a turbulent time.

US scientists win Nobel Prize for Medicine for discovering microRNA

American researchers Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering discovery of microRNA.

AZ's Dr Sunil Verma on the next chapter in cancer care

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.

Orange lungs on yellow background

Sanofi and Regeneron's allergy drug is first biologic for COPD

Sanofi and Regeneron have announced that dupilumab has received an FDA approval in COPD and an eosinophilic phenotype.

Handshake on blue background

Novo Nordisk expands stem cell research arm with Evotec

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Cracking compliance in the US: Key points for pharma to remember

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

Moderna’s Chantal Friebertshäuser on improving vaccine confidence

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.